Are you Dr. Konrad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 33 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Lilly Corporate Ctr
Bldg 98A3
Indianapolis, IN 46285Phone+1 317-655-9290Fax+1 317-276-5281
Summary
- Dr. Robert Konrad, MD is a board certified pathologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Alabama, and Pennsylvania.
Education & Training
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1991 - 1996
- Perelman School of Medicine at the University of PennsylvaniaClass of 1991
Certifications & Licensure
- IN State Medical License 2001 - 2025
- PA State Medical License 1994 - 2004
- AL State Medical License 1998 - 2002
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 45 citationsApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition.Yan Q. Chen, Thomas G. Pottanat, Eugene Y. Zhen, Robert W. Siegel, Mariam Ehsani
Journal of Lipid Research. 2021-03-21 - 38 citationsHealthy Individuals Carrying the PCSK9 p.R46L Variant and Familial Hypercholesterolemia Patients Carrying PCSK9 p.D374Y Exhibit Lower Plasma Concentrations of PCSK9Steve E. Humphries, R. Dermot G. Neely, R. Whittall, Jason S. Troutt, Robert J. Konrad
Clinical Chemistry. 2009-12-01 - 38 citationsTumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the LungTimothy R. Holzer, Angie D. Fulford, Drew M. Nedderman, Tara S. Umberger, Rebecca R. Hozak
Plos One. 2013-11-14